GLYCOBIEN
Live / Registered — Registered and renewed (as of 14 Sept 2018)
What this means for you
Registered since 22 Jul 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Jul 2018).
Record
- Serial number
- 78903733
- Registration number
- 3472313
- Mark type
- Stylized text
- Filed
- 08 Jun 2006
- Published for opposition
- 06 May 2008
- Registered
- 22 Jul 2008
- Next maintenance due
- 22 Jul 2018
- Attorney of record
- Aleksandar Nikolic
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used to regulate blood sugar levels to treat diabetes; pharmaceutical preparations to lower blood sugar levels; pharmaceutical preparations to control insulin levels for the treatment of polycystic ovary syndrome; metformin
Owner
- Orx Pharmaceutical Corp., Scarborough, Ontario, CA
- Orx Pharmaceutical Corp., Scarborough, Ontario, CA
- Orx Pharmaceutical Corp., Scarborough, Ontario, CA
Prosecution history
- 14 Sept 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Sept 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Sept 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Aug 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Aug 2018 — TEAS SECTION 8 & 9 RECEIVED
- 23 Feb 2016 — WITHDRAWAL OF ATTORNEY GRANTED
- 23 Feb 2016 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 31 Jul 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 31 Jul 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 31 Jul 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Jul 2014 — TEAS SECTION 8 RECEIVED
- 22 Jul 2008 — REGISTERED-PRINCIPAL REGISTER
- 06 May 2008 — PUBLISHED FOR OPPOSITION
- 16 Apr 2008 — NOTICE OF PUBLICATION
- 29 Mar 2008 — LAW OFFICE PUBLICATION REVIEW COMPLETED